Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 771 of 6351
-
Could earlier aspirin save lives in sickle cell pregnancies?
Disease control OngoingThis study is being conducted to evaluate the safety and effect of starting daily use of low dose (100 mg) aspirin in pregnant women with sickle cell disease, who are being followed in two county hospitals in Angola, in the first trimester versus the second trimester of the gesta…
Phase 1/2 • Sponsor: Instituto Nacional de Investigacao em Saude, Angola • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a Pre-IVF pill boost baby chances for endometriosis patients?
Disease control OngoingA Phase 3 clinical trial of oral GnRH antagonist pre-treatment for women with endometriosis who are undergoing IVF, with a primary outcome of live birth rate. The investigators' central hypothesis is that in infertile woman with endometriosis undergoing in vitro fertilization-emb…
Phase 3 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New heart valve trial offers hope for thousands with stiff heart valves
Disease control By invitation onlyThe objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, severe native aortic stenosis who are considered intermediate or low risk for surgical mortality. Th…
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Eye drops could replace needles for Diabetes-Related vision loss
Disease control CompletedThe primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS 01 as compared to Vehicle in participants with Diabetic Macular Edema (DME).
Phase 3 • Sponsor: Oculis • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug duo aims to tame aggressive lymphoma without chemo
Disease control Recruiting nowTo learn if obinutuzumab in combination with CC-99282 can help to control previously untreated, high tumor burden FL
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
HIIT may boost heart health after stroke, new trial shows
Disease control OngoingObjective. To assess the effect of innovative "High-Intensity Interval Training" (HIIT) on Heart Rate Variability, a strong biomarker of positive outcome after stroke. Design. A randomized controlled study with blinded assessment of the main criteria. Population. NIHSS\<20 post…
Sponsor: Hôpital Léon Bérard • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can heat and antifungals team up to beat a stubborn skin fungus?
Disease control Recruiting nowSporotrichosis is a chronic granulomatous mycosis caused by sporothrix complex. The course of sporotrichosis is always prolonged and even life-threatening, the treatment of this disease in an important scientific problem to be solved. The investigators previously found the predom…
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New weekly shot could help diabetics with kidney trouble control blood sugar
Disease control OngoingThe purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and renal impairment, with inadequate glycemic control on basal insulin alone or a combination of basal insulin with or without metformin …
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a simple timing change make stem cell transplants safer?
Disease control Recruiting nowTo observe the effect of stem cell infusion on the development of acute graft- versus-host disease (aGVHD) in patients with nonmalignant hematologic diseases after allogeneic peripheral blood hematopoietic stem cell transplantation (allo-PBSCT)
Phase 3 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can tiny threads in acupuncture points curb obesity?
Disease control CompletedThe investigators describe a protocol for a randomized controlled trial to find out the effect and safety of acupoint thread embedding on losing weight in obese patients.
Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Online therapy aims to calm the fear of heart trouble when the heart is fine
Symptom relief OngoingNon-cardiac chest pain (NCCP) is a common condition that significantly affects patients' mental well-being, overall quality of life, and healthcare use. Even after ruling out cardiac issues, many patients still worry about having an undiagnosed cardiac illness, leading to cardiac…
Sponsor: Linkoeping University • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
Could a second round of radiation boost survival in returning brain tumors?
Disease control Recruiting nowDespite comprehensive multimodal treatment of newly diagnosed glioblastoma, almost all patients suffer from tumour relapse. Currently, no standard of care exists to treat these tumour relapses. Treatment options include repeated surgery (if feasible), systemic therapy (bevacizuma…
Phase 3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Could cooling Babies' brains after mild birth injury boost IQ?
Disease control Recruiting nowThe goal of this randomised control trial is to establish the safety and efficacy of whole-body hypothermia for babies with mild hypoxic ischaemic encephalopathy, inform national and international guidelines, and establish uniform practice across the NHS. The main questions it a…
Phase 3 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New blood test could end guesswork in liver cancer diagnosis
Diagnosis Recruiting nowIt is sometimes difficult to precisely understand whether a primary liver cancer is a hepatocellular carcinoma or a cholangiocarcinoma. The researchers will develop and validate a liquid biopsy, based on exosomal content analysis and powered by machine learning, to help clinician…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Teen depression breakthrough? sleep therapy targets body clock
Symptom relief Recruiting nowThe overall aim of this proposal is a confirmatory efficacy trial sufficiently powered and designed to test the hypothesis that improving the relationship between biological circadian timing and waketime, a novel modifiable target, improves depression outcomes in a subgroup of ad…
Sponsor: Children's Hospital Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could microwaves replace mammograms? new study tests safer, more comfortable breast cancer screening
Diagnosis Recruiting nowThis is an open, multicentric, interventional, prospective, non-randomized clinical investigation. The first aim of the study is to confirm that MammoWave reaches sensitivity\>75% and specificity\>90% in breast cancer (BC) detection on 10.000 volunteers undergoing regular screeni…
Sponsor: Umbria Bioengineering Technologies • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
New TB vaccine trial aims to stop infection before it starts
Vaccine OngoingTuberculosis (TB) is an infection caused by bacteria passed from one person to another through the air when an infected person for instance coughs, speaks, or sneezes. This study tests the safety and vaccine-induced immune response of a new preventive TB vaccine called H107e/CAF®…
Phase 1 • Sponsor: Statens Serum Institut • Aim: Vaccine
Last updated Jun 27, 2026 11:00 UTC
-
New hope for Hard-to-Treat cancers: NUV-1511 enters human trials
Disease control OngoingNUV-1511-01 is a first-in human, open- label, Phase 1/2 to evaluate the safety and efficacy of NUV-1511 in patients with advanced solid tumors. The Phase 1 portion include patients with advanced solid tumors and is designed to determine the safety and the tolerability of doses of…
Phase 1/2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Phone app could stop PTSD and pot addiction after assault
Prevention Recruiting now683,000 women are sexually assaulted annually in the United States, half of whom develop chronic posttraumatic stress disorder (PTSD) and thus have markedly increased risk for cannabis use disorder (CUD). The current proposal will test the acceptability, initial efficacy, and mec…
Phase 1/2 • Sponsor: University of Nevada, Las Vegas • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Promising lupus drug anifrolumab now tested in kids
Disease control Recruiting nowA Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Efficacy, and Safety of Anifrolumab in Children with Moderate to Severe Active Systemic Lupus Erythematosus (SLE)
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC